Putting it All Together in Bipolar Disorder: Novel Treatment Options Focused on the Whole Patient

The burden among adults living with bipolar ll disorder (BD2) is significant and effective identification and management remains a clinical challenge. A handful of therapies with novel mechanisms of action are emerging to better address the varied symptoms of BD2. In this session, expert faculty will explain ways to differentiate between BD2 and MDD; assess the impact of cardiometabolic burden on treatment adherence; update knowledge regarding the mechanisms of action, clinical indications, and pharmacotherapeutic characteristics of novel and emerging agents; as well as outline strategies to integrate these agents into patient-centered treatment. Join our faculty in a live Q&A session immediately following their presentation where they will answer the most popular questions asked during this session. Supported by an educational grant from Intra-Cellular Therapies, Inc.